Examples of using P-values in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
P-values compared to pamidronate.
A difference was considered as statistical significant for p-values< 0.05.
A p-values based on Chi-squared test.
Days for those treated with pamidronate 90 mg p-values: 0.001 for 4 mg and 0.007 for 8 mg zoledronic acid.
P-values for olanzapine and quetiapine XR vs. placebo were unadjusted.
HR and p-values from Cox regression models adjusting for important prognostic factors.
All p-values are pairwise comparisons of proportions for Trudexa versus placebo.
B p-value for time to deterioration based on stratified log-rank test c p-values were not adjusted for multiplicity.
P-values were< 0.001 for both mTSS
75.1 x 109/L, respectively. b Estimates and p-values are based on an ANCOVA model.
P-values for comparison versus pre-Tx values were computed using paired t-tests.
clinically meaningful, with p-values ranging from 0.009 to< 0.0001.
Tho 100 All p-values are pairwise comparisons of proportions for Trudexa versus placebo* p< 0.001.
was 30 to 40 days for patients treated with Zometa versus 17 days for those treated with pamidronate 90 mg p-values.
All p-values are pairwise comparisons of proportions for Humira versus placebo* p<
of albumin-corrected serum calcium 2.9 mmol/l) was 30 to 40 days for patients treated with zoledronic acid versus 17 days for those treated with pamidronate 90 mg p-values: 0.001 for 4 mg and 0.007 for 8 mg zoledronic acid.
Other studies: p-values compared each efalizumab group with placebo using Fisher's exact test within each study. p< 0.001.
P-values were derived from comparison for change from baseline within analysis of covariance model with treatment as term
1.6 Pairwise comparison p-values:† p<
IMP24011: p-values compared efalizumab with placebo using logistic regression including baseline PASI score,
P-values< 0.05 were shown for PC
Pairwise comparison p-values:* p<
All p-values< 0.001 for all comparisons between Xiapex and placebo, except for PIP joints in
P-values for URAI refer to the null hypothesis that efficacy differed between subgroup strata(URAI,
P-values< 0.05 comparing pemetrexed/ cisplatin to gemcitabine/ cisplatin, using Fisher Exact test.**Refer
Reduction, p-value for rate ratio.
Reduction, p-value for rate ratio Emergency visits.
And with a p-value of less than 0.
Reduction, p-value for rate ratio Physician' s overall assessment.
A values presented for GIOTRIF vs. erlotinib, p-value based on logistic regression.